vs
Side-by-side financial comparison of GENCOR INDUSTRIES INC (GENC) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
SBC Medical Group Holdings Inc is the larger business by last-quarter revenue ($39.6M vs $23.6M, roughly 1.7× GENCOR INDUSTRIES INC). SBC Medical Group Holdings Inc runs the higher net margin — 35.9% vs 14.6%, a 21.3% gap on every dollar of revenue. On growth, SBC Medical Group Holdings Inc posted the faster year-over-year revenue change (-10.9% vs -25.0%). SBC Medical Group Holdings Inc produced more free cash flow last quarter ($51.2M vs $10.1M). Over the past eight quarters, SBC Medical Group Holdings Inc's revenue compounded faster (-15.0% CAGR vs -23.9%).
Gencor Industries Inc is a leading manufacturer of heavy construction and infrastructure equipment, specializing in asphalt production plants, thermal combustion systems, and supporting road-building machinery. It primarily serves North American and global construction markets, supplying products to both public sector infrastructure projects and private commercial construction operators.
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
GENC vs SBC — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $23.6M | $39.6M |
| Net Profit | $3.4M | $14.2M |
| Gross Margin | 28.7% | 73.1% |
| Operating Margin | 13.2% | 32.5% |
| Net Margin | 14.6% | 35.9% |
| Revenue YoY | -25.0% | -10.9% |
| Net Profit YoY | -9.8% | 117.2% |
| EPS (diluted) | $0.23 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $23.6M | $39.6M | ||
| Q3 25 | $18.8M | $43.4M | ||
| Q2 25 | $27.0M | $43.4M | ||
| Q1 25 | $38.2M | $47.3M | ||
| Q4 24 | $31.4M | $44.4M | ||
| Q3 24 | $20.9M | $53.1M | ||
| Q2 24 | $25.6M | $53.1M | ||
| Q1 24 | $40.7M | $54.8M |
| Q4 25 | $3.4M | $14.2M | ||
| Q3 25 | $1.9M | $12.8M | ||
| Q2 25 | $3.8M | $2.5M | ||
| Q1 25 | $6.1M | $21.5M | ||
| Q4 24 | $3.8M | $6.5M | ||
| Q3 24 | $1.5M | $2.8M | ||
| Q2 24 | $2.6M | $18.5M | ||
| Q1 24 | $6.2M | $18.8M |
| Q4 25 | 28.7% | 73.1% | ||
| Q3 25 | 24.2% | 70.6% | ||
| Q2 25 | 26.5% | 69.2% | ||
| Q1 25 | 29.7% | 79.7% | ||
| Q4 24 | 27.6% | 76.3% | ||
| Q3 24 | 25.6% | 81.5% | ||
| Q2 24 | 23.9% | 74.2% | ||
| Q1 24 | 30.3% | 72.1% |
| Q4 25 | 13.2% | 32.5% | ||
| Q3 25 | -1.2% | 36.6% | ||
| Q2 25 | 11.6% | 33.6% | ||
| Q1 25 | 17.0% | 51.1% | ||
| Q4 24 | 14.7% | 10.6% | ||
| Q3 24 | 5.9% | 26.1% | ||
| Q2 24 | 7.8% | 51.4% | ||
| Q1 24 | 17.4% | 44.6% |
| Q4 25 | 14.6% | 35.9% | ||
| Q3 25 | 10.2% | 29.6% | ||
| Q2 25 | 14.2% | 5.7% | ||
| Q1 25 | 16.0% | 45.4% | ||
| Q4 24 | 12.1% | 14.7% | ||
| Q3 24 | 6.9% | 5.3% | ||
| Q2 24 | 10.0% | 34.8% | ||
| Q1 24 | 15.3% | 34.2% |
| Q4 25 | $0.23 | $0.15 | ||
| Q3 25 | $0.13 | $0.12 | ||
| Q2 25 | $0.26 | $0.02 | ||
| Q1 25 | $0.42 | $0.21 | ||
| Q4 24 | $0.26 | $0.05 | ||
| Q3 24 | $0.10 | $0.03 | ||
| Q2 24 | $0.17 | $0.20 | ||
| Q1 24 | $0.42 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $147.7M | $164.1M |
| Total DebtLower is stronger | — | $42.8M |
| Stockholders' EquityBook value | $215.2M | $248.3M |
| Total Assets | $228.9M | $380.4M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $147.7M | $164.1M | ||
| Q3 25 | $136.3M | $127.4M | ||
| Q2 25 | $136.0M | $152.7M | ||
| Q1 25 | $143.7M | $132.1M | ||
| Q4 24 | $130.1M | $125.0M | ||
| Q3 24 | $115.4M | $137.4M | ||
| Q2 24 | $116.6M | — | ||
| Q1 24 | $117.1M | — |
| Q4 25 | — | $42.8M | ||
| Q3 25 | $0 | $21.1M | ||
| Q2 25 | — | $7.1M | ||
| Q1 25 | — | $6.9M | ||
| Q4 24 | — | $6.6M | ||
| Q3 24 | $0 | $823.2K | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $215.2M | $248.3M | ||
| Q3 25 | $211.8M | $248.0M | ||
| Q2 25 | $209.9M | $244.6M | ||
| Q1 25 | $206.1M | $226.4M | ||
| Q4 24 | $200.0M | $195.1M | ||
| Q3 24 | $196.1M | $205.0M | ||
| Q2 24 | $194.7M | $8.8M | ||
| Q1 24 | $192.1M | $9.0M |
| Q4 25 | $228.9M | $380.4M | ||
| Q3 25 | $222.6M | $321.4M | ||
| Q2 25 | $220.2M | $315.3M | ||
| Q1 25 | $223.9M | $284.6M | ||
| Q4 24 | $218.2M | $266.1M | ||
| Q3 24 | $208.1M | $296.5M | ||
| Q2 24 | $201.8M | $19.5M | ||
| Q1 24 | $206.0M | $19.8M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | 0.00× | 0.09× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | — | 0.03× | ||
| Q3 24 | 0.00× | 0.00× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $11.1M | $52.0M |
| Free Cash FlowOCF − Capex | $10.1M | $51.2M |
| FCF MarginFCF / Revenue | 43.0% | 129.3% |
| Capex IntensityCapex / Revenue | 4.1% | 2.0% |
| Cash ConversionOCF / Net Profit | 3.23× | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | $-3.2M | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $11.1M | $52.0M | ||
| Q3 25 | $-275.0K | $-20.9M | ||
| Q2 25 | $-23.9M | $-8.3M | ||
| Q1 25 | $12.4M | $1.9M | ||
| Q4 24 | $14.8M | $-7.3M | ||
| Q3 24 | $-3.2M | $5.0M | ||
| Q2 24 | $-1.0M | $19.2M | ||
| Q1 24 | $11.7M | $3.7M |
| Q4 25 | $10.1M | $51.2M | ||
| Q3 25 | $-1.3M | $-20.9M | ||
| Q2 25 | $-24.4M | $-8.6M | ||
| Q1 25 | $12.3M | $1.7M | ||
| Q4 24 | $14.5M | $-7.9M | ||
| Q3 24 | $-3.3M | $4.6M | ||
| Q2 24 | $-1.4M | $18.3M | ||
| Q1 24 | $11.7M | $3.0M |
| Q4 25 | 43.0% | 129.3% | ||
| Q3 25 | -6.8% | -48.3% | ||
| Q2 25 | -90.4% | -19.9% | ||
| Q1 25 | 32.2% | 3.5% | ||
| Q4 24 | 46.1% | -17.8% | ||
| Q3 24 | -15.8% | 8.7% | ||
| Q2 24 | -5.6% | 34.5% | ||
| Q1 24 | 28.7% | 5.4% |
| Q4 25 | 4.1% | 2.0% | ||
| Q3 25 | 5.4% | 0.1% | ||
| Q2 25 | 1.8% | 0.7% | ||
| Q1 25 | 0.4% | 0.5% | ||
| Q4 24 | 1.0% | 1.3% | ||
| Q3 24 | 0.4% | 0.8% | ||
| Q2 24 | 1.5% | 1.6% | ||
| Q1 24 | 0.0% | 1.3% |
| Q4 25 | 3.23× | 3.66× | ||
| Q3 25 | -0.14× | -1.63× | ||
| Q2 25 | -6.24× | -3.39× | ||
| Q1 25 | 2.04× | 0.09× | ||
| Q4 24 | 3.88× | -1.12× | ||
| Q3 24 | -2.22× | 1.77× | ||
| Q2 24 | -0.41× | 1.04× | ||
| Q1 24 | 1.87× | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GENC
Segment breakdown not available.
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
